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ABSTRACT 
   Inorganic arsenic species are metabolized to monomethylarsonic acid (MMA V) and 
dimethylarsinic acid (DMA V) and excreted into urine.   A simple, rapid and sensitive 
method has been developed using electrospray ionization tandem mass spectrometry 
(ESI–MS–MS) for the simultaneous determination of MMA V and DMA V.    MMA V 
and DMA V in a sample were allowed to react with citric acid (CiA).  Adduct 
compounds were extracted together with isoamyl alcohol (IAA).     An aliquot 
(1-μL) of the IAA layer was directly injected into the ESI–MS–MS instrument, and was 
detected within 1 min.   Quantification was done using selected reaction monitoring 
for MMA V and DMA V as follows.  
[MMAH + 2CiA − 3H2O]+   →   [MMAH + CiA − 2H2O]+   
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[DMAH + CiA + MeOH − 2H2O]+  →   [DMAH + MeOH − H2O]+   
Where, MMAH and DMAH denote the protonated forms of MMA V and DMA V, and 
MeOH denotes methanol (carrier liquid in ESI–MS–MS).    This method was 
validated for the analysis of urine samples.  The limit of detection of As was 0.3 μgL–1 
for MMA V and 0.6 μgL–1 for DMA V using 10 μL of sample solution.  Results were 
obtained in <10 min with a linear calibration range of 3–100 μgL–1.  Inorganic arsenic 
compounds (and other organic arsenic compounds) found in urine did not interfere with 
the detection of MMA V and DMA V.    Concentrations of MMA V and DMA V in the 
reference urine SRM 2670a were estimated after partial purification, and those in urine 
of a patient treated with As2O3 were measured after dilution.  
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1. Introduction 
   Inorganic arsenic species such as arsenite (AsIII) and arsenate (AsV) in drinking 
water at levels of several hundred micrograms per liter are known to induce cancers of 
skin, liver, lung, bladder and kidney as well as disorders of circulatory and nervous 
systems in human body [1,2].   On the other hand, As2O3 is administered 
intravenously to acute promyelocytic leukemia patients at a daily dose of 0.15 mgkg–1 
body weight in some medical treatment [3].  The absorbed As is metabolized by 
consecutive reduction and oxidative methylation mainly to monomethylarsonic acid 
(MMAV), monomethylarsonous acid (MMAIII), dimethylarsinic acid (DMAV), and 
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dimethylarsinous acid (DMAIII) [1-5].   Here, MMAIII and DMAIII are more toxic 
whereas MMAV and DMAV are less toxic than inorganic arsenic species, respectively 
[1-5].    They are then excreted into urine mostly in the form of MMAV and DMAV 
since MMAIII and DMAIII are chemically labile compounds.   Other organic As 
compounds such as arsenobataine (AsB), arsenocholin (AsC) and arsenosugars are 
contained abundantly (usually in the mgkg–1 range) in fish, mussel and algae [6], but 
their toxicity is low.   For example, AsB is excreted into urine quickly and unchanged.     
   Many analytical techniques have been employed to separate and quantify these 
various arsenic compounds having different toxicities.   Liquid 
chromatography–inductively-coupled plasma–mass spectrometry (LC–ICP–MS) 
produced a high selectivity in determining atomic mass m/z = 75 of As and high 
sensitivity having a limit of detection (LOD) of 0.14–0.33 μgL–1 [5].   LC–ICP–MS 
offers a great advantage in quantification of atoms, but identification of chemical 
species containing certain atoms is based entirely on agreement of the chromatographic 
retention time with that of available reference chemical species.   In some 
chromatographic separations, highly toxic inorganic AsIII elutes together with MMAV 
[5,7] or negligibly toxic AsB [6,7], and in other separation, the peak of 
dimethylthioarsenical was mis-assigned as that of DMAIII [2].   The atomic mass in 
the detection of 75As, m/z = 75, is easily interfered with by isobars such as FeOH [8] 
and ArCl resulting from the combination of Ar from plasma gas and Cl from the sample 
solution [5,8].   
   Electrospray ionization (ESI) mass spectrometry (MS) provides a unique 
opportunity for the analysis of molecular forms of species [4,9-11].   Before 1997, 
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MMAV (and sometimes DMAV) could not be quantified on ESI–MS, and only 
qualitative data were provided in reports [9,11] because they are quite soluble in water 
and are difficult to ionize.  Subsequent studies succeeded in the quantification, but 
LODs for MMAV and DMAV remained unsatisfactory, i.e., 305 pg and 72 pg in 1997 
[10], and 200 pg and 78 pg in 1999 [4], respectively.   To accelerate ESI of MMAV 
and DMAV, we added several acids to aqueous samples and extracted analytes with 
polar organic solvents (e.g., isoamyl alcohol (IAA)).   In these studies, we found that 
MMAV and DMA V formed adduct ions with citric acid (CiA), having an intensity of 
20-fold that of the protonated molecular ions.   Signal enhancement due to adducts 
was also reported in anabolic steroids [12].    Adducts of MMA V and DMA V with 
CiA have not been reported, although adducts with methanol (MeOH) and ethanol used 
for the carrier liquid have [9].  The present study adopted tandem mass spectrometry 
(MS–MS) after ESI in the quantification of adducts of MMA V and DMA V to further 
increase detection sensitivity. 
  
2. Materials and methods 
   IAA suitable for nucleic acid purification was obtained from Sigma-Aldrich, USA.  
Analytical grade MMA V was obtained from Tri Chemical Laboratories Incorporated 
(Yamanashi, Japan).   Analytical grade DMA V, tetramethylarsonium (TeMA) iodide, 
AsB, AsC bromide, CiA, NaAsO2 (AsIII), Na2HAsO4 .7H2O (AsV) and other reagents 
were obtained from Wako Pure Chemicals (Osaka, Japan).  Pure water having a 
specific resistance of 18 MΩ cm was used.     
   Control urine was obtained from healthy volunteers.   Standard reference urine 
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(SRM 2670a) was purchased from the National Institute of Standards and Technology 
(Gaithersburg, MD, USA).  We used SRM 2670a because a few reports on MMAV and 
DMAV were published (although it is a standard material for 29 inorganic ions).   
   Patient urine was obtained from a woman in her late seventies diagnosed as acute 
promyelocytic leukemia, who was administered with As2O3 intravenously daily over 2 h 
at a dose of 0.15mgkg-1 for 25 consecutive days during induction therapy [3].   Void 
urine samples were collected on the last day of the therapy (day 1), 4 days after (day 5) 
and 7 days after (day 8), respectively, and were stored at - 20 °C for < 24 days before 
the assay.      
   MMAV and DMAV (1 g As L–1 in water) were the stock solutions.   Calibration 
standard solutions and quality-control solutions were prepared by spiking stock 
solutions at 0, 3, 6, 10 and 100 μg As L–1 to water and urine that contained 1 M CiA.    
   MMAV and DMA V were assayed as follows.   To 10 μL of sample or standard 
solution in a polypropylene tube with cap (Eppendorf AG, Germany), CiA as a solid (2 
mg) was added to make a solution of 1 M CiA.  CiA was not added to standard 
solutions if they contained CiA.    After 60 s, 10 μL of IAA was added, vortex-mixed 
for 60 s, and centrifuged at 5000 × g for 30 s.  The layer of IAA was used for detection 
of adducts of MMA V and DMA V.    
   When the concentrations of MMA V and DMA V in urine were <10 μg As L-1, urine 
(or spiked urine) was concentrated to tenfold as follows.  One milliliter of urine was 
passed through a cartridge for 1-mL sample (Waters Oasis Max 1cc 30 mg Extraction 
Cartridge consisted of a copolymer designed to have a hydophilic-liphophilic balance, 
WAT094225, Waters Company, Milford, MA, USA) that had been conditioned with 1 
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mL of MeOH and 1 mL of water in advance.  Then 2 mL of water was flushed through 
the cartridge to wash-out analytes thoroughly.  That is, MMA V and DMA V did not but 
some interfering substances did retain on the cartridge.  Three milliliters of aqueous 
eluate was evaporated to dryness at 100°C under air flow in a hood chamber, and the 
analytes extracted twice with 50 μL of MeOH.   One-hundred microliters of MeOH 
solution was evaporated to dryness at 45°C, and the analytes extracted twice with 10 μL 
of MeOH.  To 20 μL of MeOH, 80 μL of 1.25 M CiA solution was added, and 10 μL 
of the solution was used for analyte assay.  The treatments for urine containing MMA 
V and DMA V >10 μg As L-1 were described in section 3.3. 
   ESI–MS–MS was carried out on a TSQ 7000 LC-quadrupole mass spectrometer 
(Thermo Quest, Japan) in positive-ion mode.   One microliter of the IAA layer was 
injected using a syringe (1701 PTFE-coated; Hamilton Company, Reno, NV, USA) 
manually in direct infusion.   A characteristic spectrum appeared 30 s after sample 
injection; a sample could be injected every 60 s.   MeOH was used as a mobile phase 
at 200 μLmin–1, and the capillary temperature set at 280°C.  The electrospray voltage 
was 4.5 kV, the multiplier voltage was 1.3 kV, and the collision voltage was 10–50 V.  
Nitrogen was used as a sheath gas (469 kPa) and also as an auxiliary gas (8 units). 
Argon was a collision gas (134 kPa).     Data on MS and MS–MS were collected at 
m/z 100–480 and m/z 50–500, respectively.     Quantification in ESI–MS–MS was 
done by integration of the peak area of product ions using a calibration curve 
comprising spiked matrix samples at different concentrations.  
 
3. Results and discussion 
3.1 Production and extraction of adducts with CiA 
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   The ionization efficiency of MMA V and DMA V is quite low, and their 
quantification was not done before 1997 [9,11].   Only qualitative studies were carried 
out on protonated molecular ions (MMAH+ and DMAH+) or adduct ions of MMA V and 
DMA V with MeOH used for the carrier liquid in ESI [9,11].   We therefore added 
various acids to the solutions of MMA V and DMA V because acidic environments 
enhance ionization in positive mode.    When CiA was added, we found not only the 
ions reported previously [9,11] but also new ions such as [MMAH + 2CiA – 3H2O]+ and  
[DMAH + CiA + MeOH – 2H2O] + derived from adducts of MMA V and DMA V with 
CiA.    Solutions added with 1 M of HCl, H2SO4, HNO3, acetic acid, oxalic acid, 
oxalacetic acid, tartaric acid, phenol or ammonium formate exhibited molecular ions as 
well as ions derived from adducts with MeOH and IAA.  When 1 M of cis-aconitic 
acid or trans-aconitic acid was added to MMA V and DMA V, MMAH+ and DMAH+ 
were produced mainly but [MMAH + 2 (aconitic acid) – H2O]+ was not produced at all, 
and the production of [DMAH + aconitic acid + MeOH – H2O] + from either of the two 
aconitic acids was only 10 % of the production of [DMAH + CiA + MeOH – 2H2O] + 
from CiA.    Therefore, the OH group attached at the central carbon of CiA may have 
played an important role in the production of [MMAH + 2CiA – 3H2O]+ and [DMAH + 
CiA + MeOH – 2H2O] +.     
   The production rate of the adducts of MMA V and DMA V with CiA increased with 
concentration up to 1 M of CiA without increasing the signal of blank solution at the 
m/z in the detection for both adducts.     CiA solution at 1 M was therefore used in 
the quantification.   Efficiencies of the extraction of adducts with several organic 
solvents were then compared.   Extraction efficiency decreased in the order, IAA > 
hexanol > octanol > cyclohexanol >> methylisobutyl ketone, and the intensity of the 
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blank decreased in the order, cyclohexanol > octanol > hexanol > IAA, for both adducts.   
IAA was therefore selected as the extraction solvent.   
 
3.2 MS and MS–MS spectra    
MMA V 
   The mass spectrum of the IAA layer extracted from 200 ngL–1 MMA V in 1 M CiA 
solution is shown in Fig. 1 (a).   It shows the molecular ion MMAH+ at m/z 141, 
[MMAH + MeOH – H2O] + at m/z 155, [MMAH +2MeOH – 2H2O] + at m/z 169, 
[MMAH + CiA – 2H2O] + at m/z 297, [MMAH + CiA + MeOH – 3H2O] + at m/z 311, 
[MMAH + CiA + MeOH – 2H2O] + at m/z 329, [MMAH + CiA + 2MeOH – 3H2O] + at 
m/z 343, [MMAH + 2CiA – 4H2O]+ at m/z 453 and [MMAH + 2CiA – 3H2O]+ at m/z 
471.   Other ions having an abundance of >5 % in Fig. 1 (a) were derived from CiA.   
The intensity of an adduct ion [MMAH + 2CiA – 3H2O] + at m/z 471 was about 20-fold 
that of the molecular ion MMAH+ at m/z 141 used for the quantification in other reports 
[4,10].  The adduct ion at m/z 471 was therefore selected as the precursor ion in the 
present MS–MS.   Fig. 1 (b) shows the product ion spectrum with the collision 
voltage at 17 V.   The product ions shown there were [MMAH + 2CiA – 4H2O]+ at 
m/z 453, [MMAH + CiA – 2H2O] + at m/z 297, [MMAH + CiA – 3H2O] + at m/z 279, 
and MMAH+ at m/z 141.  The peak at m/z 297 was the main peak at the collision 
voltages from 10 to 30 V showing the highest intensity of 3600 in normalized level 
(NL) at 17 V, whereas the peak at m/z 141 was the main peak at the collision voltage 
from 30 to 50 V showing the highest intensity of 620 in NL at 35 V.   Therefore, the 
peak at m/z 297 with the collision voltage at 17 V was used for quantification.  
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DMA V 
   The mass spectrum of the IAA layer extracted from 200 ngL–1 DMA V in 1 M CiA 
solution is shown in Fig. 2 (a).   It shows the molecular ion DMAH+ at m/z 139, 
[DMAH + MeOH – H2O] + at m/z 153, [DMAH + CiA – 2H2O] + at m/z 295 and 
[DMAH + CiA + MeOH – 2H2O] + at m/z 327.    Other ions having an abundance of 
>5% in Fig. 2 (a) were derived from CiA.   The intensity of an adduct ion [DMAH + 
CiA + MeOH – 2H2O] + at m/z 327 was about 20-fold that of the molecular ion DMAH+ 
at m/z 139 used for quantification in other studies [4,10].    The adduct ion at m/z 327 
was therefore selected as the precursor ions in MS–MS analyses.   Fig. 2 (b) shows 
the product ion spectrum with the collision voltage at 18 V.   The product ions shown 
there were [DMAH + CiA + MeOH – 3H2O] + at m/z 309, [DMAH + CiA – 2H2O] + at 
m/z 295, [DMAH + MeOH – H2O] + at m/z 153 and DMAH+ at m/z 139.   The peak at 
m/z 153 was the main peak at the collision voltages from 10 to 35 V showing the 
highest intensity of 9300 in NL at 26 V, whereas the peak at m/z 121 was the main peak 
at the collision voltage from 35 to 50 V showing the highest intensity of 3300 in NL at 
40 V.   Therefore, the peak at m/z 153 with the collision voltage at 26 V was used for 
quantification.     
   CiA adducts extracted with IAA were quite stable.   In the present determination, 
90% of the complex remained after 24 h in the IAA extract from aqueous solution and 
under room light at 25°C.     
   For the quantification of MMA V and DMA V, mass chromatograms of 
selective-reaction monitoring at m/z 297 were taken for MMA V (a), and at m/z 153 for 
DMA V (b), respectively (Fig. 3).  As indicated in Fig. 3, 3 pg of As could be 
quantified in MMA V and DMA V. 
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3.3 Interference 
   The signals of MMA V and DMA V adducts did not disturb each other.  Both 
adducts in a sample could be quantified by changing the m/z values of the precursor ion 
and the product ion, as well as the collision voltage.   Interferences from various 
compounds were examined using the solution containing MMA V and DMA V at 100 
μgL–1.  Inorganic As (AsIII and AsV) and metal ions such as Ti, V, Cr, Mn, Fe, Co, Ni, 
Cu, Zn, Zr, Mo, Ru, Pd, Ag, Cd, W, Pt and Pb at 10 mgL–1 did not interfere with 
detection of MMA V and DMA V in the present assay.   Effects of organic As 
compounds such as TeMA, AsB and AsC at 100 mgL–1 were also examined.   They 
did not form adducts with CiA and did not interfere with the signal of MMA V and 
DMA V adducts in the present assay.   Recovery of >98 % was observed in the 
following solutions: <50 mM solution of cis-aconitic acid, trans-aconitic acid, HCl, 
H3PO4, H2SO4, HNO3, MgSO4, KH2PO4 or urea, <15 mM solution of NaCl, KCl, 
Na2SO4, NaNO3, NaHCO3 EDTA or nitrilotriacetic acid (NTA) for MMA V; and <50 
mM solution of of cis-aconitic acid, trans-aconitic acid, HCl, H2SO4, HNO3, MgSO4, 
KH2PO4 or urea, <15 mM solution of NaCl, KCl, Na2SO4, EDTA or NTA for DMA V.  
Solutions with higher concentrations than the ones mentioned above inhibited detection 
more strongly.   Severe matrix effects of urine have been reported in the previous 
work [10], and MMA V and DMA V in urine were not detected there.   Signals of 
MMA V and DMA V in some urine samples were only one-hundredth of those in water.  
On the contrary, these signals extracted from the urine diluted to 1/2 – 1/5 with water 
were more than twice those extracted from the undiluted urine.   Urine samples 
 11
containing MMA V and DMA V >50 μg As L–1 could be quantified only by dilution, 
whereas those for 50 to 10 μg As L–1 could be quantified by passing the urine through 
an Oasis cartridge and then diluting the eluate, since the cartridge could eliminate the 
interfering substances satisfactorily.      
 
3.4 Precision and accuracy 
   Calibration standard solutions of MMA V and DMA V were prepared by spiking 
stock solutions at 0, 3, 10 and 100 μg As L–1 to water.   Concentrations determined 
from the peak area (y) were linear to the concentrations spiked (x) up to 100 μgL–1 (i.e., 
y = 11.38 x + 1.34 with a correlation coefficient of 0.9993 for MMA V, and y = 10.83 x 
+ 28.77, with a correlation coefficient of 0.9938 for DMA V).   Precision and accuracy 
were assessed by analyses of water spiked at 3, 10 and 100 μgL–1 (Table 1).    These 
samples were analyzed three times a day, as well as on three different days.   The 
coefficient of variation was <24 %, and accuracy was 83–105 % for intra-day and 
inter-day variations.   The limit of quantification (LOQ) of the present method was 
therefore 3 μgL–1 for MMA V or DMA V in aqueous solutions that contained 
non-interfering substances certified in the Interference section.     Blanks that were 
not spiked with MMA V and DMA V were measured six times, and their standard 
deviations (σ) were calculated in pg based on the calibration.   LODs in the present 
assay were 0.3 μgL–1 for MMA V and 0.6 μgL–1 for DMA V because LOD was defined 
to be 3σ for blank signals [5].      
   In case of urine containing MMA V and DMA V <10 μg As L–1, calibration standard 
solutions were prepared by spiking stock solutions at 0, 3, 6 and 10 μg As L–1 to urine 
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and were concentrated to tenfold as explained in Materials and method.   The 
concentration was expressed as that in the original urine although the quantification was 
performed using urine concentrated to tenfold.   Concentrations determined from the 
peak area (y) were linear to the concentrations spiked (x) up to 10 μgL–1 (i.e., y = 20.49 
x + 34.51 with a correlation coefficient of 0.9927 for MMA V, and y = 16.21 x + 51.65, 
with a correlation coefficient of 0.9857 for DMA V).   Precision and accuracy were 
listed in Table 2, and the coefficient of variation was <19 % and accuracy was 
85–108 %.  The LOQ was therefore 3 μgL–1 for MMA V or DMA V in urine.   Urine 
samples not spiked with MMA V and DMA V were measured six times, and LODs were 
0.40 μgL–1 for MMA V and 0.41 μgL–1 for DMA V [5].      
   To check the recovery and validate the proposed procedure, standard reference urine, 
2670a high-level urine, and low-level urine were examined.  High-level and low-level 
urine indicate only the levels of inorganic ions.    Reference urine, control urine and 
spiked urine were treated as described in the Methods and materials section because 
urine contains large amounts of interfering substances [10].   Figure 4 shows the 
results of urine samples.  That is, blank, control urine, high-level urine (spiked at 0, 3 
or 6 μgL–1) and low-level urine (spiked at 0, 3 or 6 μgL–1), respectively.    The results 
indicated that MMA V and DMA V at 3 μgL–1 could be quantified in high-level urine and 
low-level urine, suggesting that the LOQ for MMA V or DMA V was 3 μgL-1 in urine.    
We tried to quantify the concentrations of MMA V and DMA V in the reference urine, 
although these were only estimated values.    Concentrations of MMA V and DMA V 
in high-level urine were 0.39±0.02 and 2.0±0.1 μgL–1, respectively, in [6]; 2.1±0.4 
μgL–1 and not detected in [2], respectively; and 0.5±0.1 and 3.3±0.1 μgL–1, 
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respectively, in this study.    Concentrations of MMA V and DMA V in low-level urine 
were 0.34±0.02 and 1.2±0.1 μgL-1, respectively in [6]; and 1.3±0.2 and 2.0±0.2 
μgL-1, respectively, in this study.    
 
3.5 Determination of MMA V and DMA V in patient urine 
   Assay was made with 1 μL of each of the three void urine samples (day 1, 5 and 8) 
added to 9 μL of water.   The concentrations of MMA V on day 1, 5 and 8 were 226±
21, 154±3 and 80±2 μgL-1, respectively (n=3), showing a significant decrease, 
whereas those of DMA V were 833±44, 684±55 and 634±9 μgL-1, respectively (n=3), 
retaining higher levels than those of MMA and showing a smaller decrease.   Indeed, 
the concentrations of DMA V on day 1, 5 and 8 were 3.9, 4.4 and 7.9 times those of 
MMA V, respectively.   Such higher concentrations of DMA V than those of MMA V 
were also reported on urines of inhabitants drinking well water polluted with As [1,5].     
  Compared with other ESI–MS–MS having an LOD of 72–305 pg in 1-μL injection 
[4,10], the present ESI–MS–MS has a much better LOQ (3 pg in 1-μL injection).   
Only by diluting urine with water, MMA V and DMA V can be assayed for urine 
collected from inhabitants in As-affected areas showing a high level of 56 μgL–1 and 
161 μgL–1, respectively [1], as well as urine from patients treated with As2O3 as in the 
present case.   One of the reasons for much better sensitivity in the present method 
than that reported previously may be due to the 20-fold higher production of the CiA 
adduct ion than that of the molecular ion (Fig. 1 (a) and Fig. 2 (a), respectively).     
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Conclusion 
   Herein, we propose an ESI-MS-MS method for the simple, rapid and decisive 
determination of monomethylarsonic acid and dimethylarsinic acid after adduct 
formation with citric acid.   The extraction of the adducts with isoamyl alcohol 
facilitated not only the ionization of the adducts but also the elimination of interfering 
substances in urine.  Hence, it enabled a direct-flow-injection that gave the MS-MS 
data within 1 min.   The isoamyl alcohol extract used for the determination of the 
adducts was available for the determination of AsB, AsC and TeMA only by changing 
the precursor ion and the product ion in the MS-MS, respectively.    
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Table 1 
Intra-day (3 times) and inter-day (3 days) variations of As values determined by the present method.   
The observed values and coefficient of variations (C.V.) for As spiked at 3 -100  
μgL-1 in case of MMA (A) and DMA (B), respectively. 
 
           Intra-day 
           A               B         
 Spiked   Observed        Observed  
  As      As      C.V.     As    C.V.
  μgL-1        μgL-1       %      μgL-1       % 
     Inter-day 
     A                  B  
     Observed          Observed   
      As     C.V.    As     C.V. 
          μgL-1         %             μgL-1         % 
 
   3  
  10 
 100 
 
 2.67  
 9.94 
 99.7  
   
  8.4 
  4.4 
  2.6 
  
 2.66 
 10.13 
 95.1 
 
 23.9 
  4.3 
 10.2 
 
2.86 
9.26 
 100.1 
   
 9.7 
 6.9 
 3.3 
 
2.49 
10.84 
 104.8 
  
 10.0 
 22.4 
3.8 
 
Table 2 
Intra-day (3 times) and inter-day (3 days) variations of As values in urine concentrated to tenfold and 
determined by the present method.   The observed values and coefficient of variations (C.V.) for As 
spiked at 3, 6, 10 μgL-1 in case of MMA (A) and DMA (B), respectively. 
 
           Intra-day 
           A                B         
 Spiked   Observed         Observed  
  As      As       C.V.     As   C.V. 
  μgL-1        μgL-1          %           μgL-1      % 
      Inter-day 
      A                B  
      Observed         Observed   
      As    C.V.      As     C.V. 
          μgL-1        %               μgL-1         % 
 
   3  
   6 
  10 
 
 2.56  
 5.31 
 9.25  
   
  3.5 
  7.7 
  8.2 
  
 2.76 
 6.45 
 10.4 
 
  2.0 
  4.5 
  5.8 
 
2.73 
5.74 
 10.1 
   
 18.9 
 12.7 
10.0 
 
2.78 
6.48 
 10.7 
  
  7.7 
  7.5 
 6.0 
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Figure captions 
 
 
 
Figure 1: Mass spectrum of the layer of isoamyl alcohol extracted from 200 ngL–1 of MMA V in 1 M citric acid (a) 
and the product ion spectrum at collision voltage of 17 V from the precursor ion [MMAH + 2CiA – 3H2O]+ at m/z 
471 (b).  The signal at m/z 141 is due to the molecular ion, and m/z values of ions related to MMA V are denoted.  
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Figure 2: Mass spectrum of the layer of isoamyl alcohol extracted from 200 ngL–1 of DMA V in 1 M citric acid (a) 
and the product ion spectrum at collision voltage of 18 V from the precursor ion [DMAH + CiA + MeOH – 2H2O]+ at 
m/z 327 (b).  The signal at m/z 139 is due to the molecular ion, and m/z values of ions related to DMA V are denoted.  
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Figure 3: Mass chromatograms of selected reaction monitoring at m/z 297 derived from the precursor ion at m/z 471 
for the quantification of MMA V in water (a), and those at m/z 153 derived from the precursor ion at m/z 327 for the 
quantification of DMA V in water (b).    Samples were injected six times for each As concentration.  
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Figure 4: Mass chromatograms of selected reaction monitoring at m/z 297 derived from the precursor ion at m/z 471 
for the quantification of MMA V in treated urine (a), and those at m/z 153 derived from precursor ion at m/z 327 for 
the quantification of DMA V in treated urine (b).    Samples were injected three times for each As concentration.  
